RSRong-Yaun Shyu

Rong-Yaun Shyu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rong-Yaun Shyu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Fu-Ming Tsai

    Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan

    2 shared publications
  • Chang-Chieh Wu

    Department of Surgery, Tri-Service General Hospital, 325 Chengung Rd, Sec 2, Taipei, 114 Taiwan

    1 shared publication
  • Chia-Ling Chen

    Department of Nutrition, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan, Republic of China

    1 shared publication
  • Chih-Chiao Yang

    Department of Social Services, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan, Republic of China

    1 shared publication
  • Chiu-Hui Su

    Center of Chest Medicine Examination, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan, Republic of China

    1 shared publication
  • Chou-Chin Lan

    Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan

    1 shared publication

Latest Publications

  • Open Access

    Translating Gastric Cancer Genomics into Targeted Therapy: Mechanistic Insights from Animal Models and Patient-Derived Systems

    by Rong-Yaun Shyu, Lu-Kai Wang, Fu-Ming Tsai

    Gastric cancer remains a leading cause of cancer-related mortality worldwide and is marked by pronounced molecular heterogeneity. Advances in genomic profiling have identified key genetic alterations, including oncogenes (HER2, PIK3CA, and MYC), tumor suppressor genes (TP53, CDH1, and ARID1A), and regulators of genome stability and cell architecture (MLH1, RHOA, and CLDN18), which have driven the development of targeted therapeutic strategies. Although genetically engineered mouse models and xenograft systems have been indispensable for functional validation and preclinical drug testing, many approaches that showed promising efficacy in animal models—such as inhibition of EGFR, MET, FGFR2, and the PI3K pathway—failed to translate into overall survival benefits in clinical trials, highlighting major translational limitations. In contrast, HER2- and CLDN18.2-targeted therapies represent rare but notable clinical successes, underscoring the importance of true oncogenic dependency, precise biomarker-driven patient selection, and robust preclinical validation. In this review, we systematically categorize gastric cancer-associated genes according to their biological functions, summarize representative animal models, and critically examine key successes and failures in clinical translation, emphasizing the need for biologically faithful models and precision-driven translational strategies.


  • Open Access

    Optimizing Treatment for Hospitalized Patients with COPD: A Study on the Impact of a LINE App-Based Multidisciplinary Team Approach Targeting Pharmacological Treatment, Lifestyle Changes, and Smoking Cessation

    by Hsiang-Yu Huang, Chia-Ling Chen, Yi-Ling Lin, Shu-Chuan Chen, Li-Chu Lee, Huei-Min Dai, Cheng-Yang Chiang, Yu-Fan Chang, Hsiu Lu, Mung-Rung Lee, et al.

    Background: Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition that significantly impacts patients’ health status. Effective management requires a multidisciplinary team (MDT) to address pharmacological and non- pharmacological treatments. The integration of mobile apps and devices improves COPD management by reducing symptoms and exacerbations. LINE, a commonly used communication app, enhanced team coordination and real-time decision-making. This study explored the effectiveness of LINE-based MDT interventions in hospitalized patients with COPD. Methods: This retrospective analysis included patients with COPD admitted for exacerbations and compared their outcomes before and after the implementation of LINE-based MDT care. The MDT consisted of pulmonologists, care managers, nurses, dietitians, social workers, pharmacists, respiratory therapists, and long-term care teams. A LINE group coordinated care in real-time, enabling the team to promptly review the patients’ conditions, adjust treatment plans, and provide tailored interventions. Results: The LINE-based MDT group demonstrated significantly higher intervention rates, including systemic steroids, inhaled corticosteroids, long-acting beta-agonists, long-acting muscarinic antagonists, and pulmonary rehabilitation (p< 0.05). BSRS improvement was greater in the MDT group than the non-MDT group (40.9% vs 29.7%, p = 0.016). However, there were no significant differences between the groups’ readmission rates, emergency room visits, or one year survival (p> 0.05). Conclusion: Implementing LINE-based MDT care significantly improved the delivery of pharmacological and non-pharmacological interventions, enhanced coordination, and facilitated comprehensive management, leading to better quality of life outcomes, as evidenced by improvements in BSRS scores. This highlights the value of leveraging real-time communication tools like LINE app to optimize COPD care.


  • Open Access

    Induction of apoptosis by the retinoid inducible growth regulator RIG1 depends on the NC motif in HtTA cervical cancer cells

    by Fu-Ming Tsai, Rong-Yaun Shyu, Su-Ching Lin, Chang-Chieh Wu, Shun-Yuan Jiang

    Background: Retinoid-inducible gene 1 (RIG1), also known as tazarotene-induced gene 3 or retinoic-acid receptor responder 3, is a growth regulator, which induces apoptosis and differentiation. RIG1 is classified into the NC protein family. This study investigated functional domains and critical amino acids associated with RIG1-mediated cell death and apoptosis. Results: Using enhanced green fluorescence protein (EGFP)-tagged RIG1 variants, RIG1 proteins with deletion at the NC domain significantly decreased cell death induced by RIG1, and fusion variants containing only the NC domain significantly induced apoptosis of HtTA cervical cancer cells. The EGFP-RIG1-induced apoptosis was significantly decreased in cells expressing N112C113 motif double- (NC→FG) or triple- (NCR→FGE) mutated RIG1 variants. Using dodecapeptides, nuclear localization and profound cell death was observed in HtTA cells expressing wild type RIG1111–123 or Leu121-mutated RIG1111–123:L→ C peptide, but peptides double- or triple-mutated at the NC motif alone, RIG1111–123:NC→FG or RIG1111–123:NCR→FGE, were cytoplasmically localized and did not induce apoptosis. The RIG1111–123 also induced apoptosis of A2058 melanoma cells but not normal human fibroblasts. Conclusion: The NC domain, especially the NC motif, plays the major role in RIG1-mediated pro-apoptotic activity. The RIG1111–123 dodecapeptide exhibited strong pro-apoptotic activity and has potential as an anticancer drug.